At Q2 Solutions, we offer the processing of peripheral blood mononuclear cells (PBMCs) and bone marrow mononuclear cells (BMMCs) at our central laboratories across the world. All our processes are performed to globally harmonized standards ensuring consistently high yields, viability and recovery.
Global PBMC Network - 24-Hour Global Transit Time Map
Specifica, a Q2 Solutions company, is applying its proven platform for antibody discovery to generate recombinant monoclonal antibody reagents. Our in vitro display approach eliminates the need for...
ImmunXperts, a Q2 Solutions company, provides functional insights into immune-mediated adverse events. We provide in silico and in vitro methods, using T-cell activation and proliferation as a...
In examining two-group differential analysis, it is apparent that different statistical methods can yield very different results even given the same RNA-Seq input data. In particular, we have...